Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INVION LIMITED Director's Dealing 2010

Feb 16, 2010

65148_rns_2010-02-16_824b4df5-cb6c-4386-8180-efe97a2b22ac.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director MR STEPHEN JONES
Date of appointment 11 OCTOBER 2000

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

33 fully paid ordinary shares

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of
interest
Note: Provide details of the circumstances giving rise to
the relevant interest.
Stephen George Burch Jones &
Nadine Jones A/C>
Australian Technology Innovation
Fund Limited. (Mr Jones is a
director
and
shareholder
in
Australian Technology Innovation
Fund Limited)
Australian Biofunds Investments
Limited (Mr Jones is a director and
shareholder in Australian Biofunds
Investments Limited)
Number & class of Securities
1,190,000 fully paid ordinary shares.
300,000 share options, with an exercise price of
$1 and an expiry date of 31 December 2012.
3,373,598 fully paid ordinary shares
199,553 fully paid ordinary shares

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract nil
Nature of interest nil
Name of registered holder
(if issued securities)
nil
No. and class of securities to
which interest relates
nil
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director DR PETER CORR
Date of appointment 30 OCTOBER 2007

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

NIL

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of
interest
Note: Provide details of the circumstances giving rise to
the relevant interest.
INOV8 LLC
Number & class of Securities
1,000,000 share options with an exercise price of
$1 and an expiry date of 31 December 2012.

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract nil
Nature of interest nil
Name of registered holder
(if issued securities)
nil
No. and class of securities to
which interest relates
nil
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director DR MICHAEL MONSOUR
Date of appointment 31 JANUARY 2007

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

nil

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of
interest
Note: Provide details of the circumstances giving rise to
the relevant interest.
MP Monsour Medical Practice Pty
Ltd Superannuation Fund A/C> (Dr
Monsour
is
a
director
and
shareholder
in
MP
Monsour
Medical Practice Pty Ltd)
MPAMM Pty Ltd (Dr Monsour is a
director
and
shareholder
in
MPAMM Pty Ltd)
Australian Technology Innovation
Fund Limited. (Dr Monsour is a
director
and
shareholder
in
Australian Technology Innovation
Fund Limited)
Australian Biofunds Investments
Limited (Dr Monsour is a director
and
shareholder
in
Australian
Biofunds Investments Limited)
Number & class of Securities
1,050,208 fully paid ordinary shares.
1,490,000 share options, with an exercise price of
$1 and an expiry date of 31 December 2012.
4,134,074 fully paid ordinary shares.
1,614,000 share options, with an exercise price of
$1 and an expiry date of 31 December 2012.
3,373,598 fully paid ordinary shares
199,553 fully paid ordinary shares

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract nil
Nature of interest nil
Name of registered holder
(if issued securities)
nil
No. and class of securities to
which interest relates
nil
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director MR JASON YEATES
Date of appointment 5 OCTOBER 2007

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

2,000,000 share options with an exercise price of $1 and an expiry date of 31 December 2012.

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of
interest
Note: Provide details of the circumstances giving rise to
the relevant interest.
Nil
Number & class of Securities

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract nil
Nature of interest nil
Name of registered holder
(if issued securities)
nil
No. and class of securities to
which interest relates
nil
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director PROFESSOR JOHN FUNDER
Date of appointment 5 OCTOBER 2007

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

NIL

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of
interest
Note: Provide details of the circumstances giving rise to
the relevant interest.
Valerie Diamond & John Funder

Dr John Funder & Ms Valerie
Funder A/C>
Number & class of Securities
100,000 fully paid ordinary shares
1,000,000 share options with an exercise price of
$1 and an expiry date of 31 December 2012.

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract nil
Nature of interest nil
Name of registered holder
(if issued securities)
nil
No. and class of securities to
which interest relates
nil
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director DR GÖRAN ANDO
Date of appointment 5 OCTOBER 2007

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

1,000,000 share options with an exercise price of $1 and an expiry date of 31 December 2012.

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of
interest
Note: Provide details of the circumstances giving rise to
the relevant interest.
NIL
Number & class of Securities

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract nil
Nature of interest nil
Name of registered holder
(if issued securities)
nil
No. and class of securities to
which interest relates
nil
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director DR DENNIS FEENEY
Date of appointment 5 OCTOBER 2007

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

NIL

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of
interest
Note: Provide details of the circumstances giving rise to
the relevant interest.
Dennis J Feeney & AH Feeney
Number & class of Securities
1,800,000 share options with an exercise price of
$1 and an expiry date of 31 December 2012.

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract nil
Nature of interest nil
Name of registered holder
(if issued securities)
nil
No. and class of securities to
which interest relates
nil
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity CBio Limited ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director MR STEPHEN STREETER
Date of appointment 25 NOVEMBER 2005

Part 1 - Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

nil

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of
interest
Note: Provide details of the circumstances giving rise to
the relevant interest.
S & M Streeter Investments Co Pty
Ltd
Australian Technology Innovation
Fund Limited. (Mr Streeter is a
director
and
shareholder
in
Australian Technology Innovation
Fund Limited)
Australian Biofunds Investments
Limited (Mr Streeter is a director
and
shareholder
in
Australian
Biofunds Investments Limited)
Number & class of Securities
105,682 fully paid ordinary shares.
1,550,000 share options, with an exercise price of
$1 and an expiry date of 31 December 2012.
3,373,598 fully paid ordinary shares
199,553 fully paid ordinary shares

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract nil
Nature of interest nil
Name of registered holder
(if issued securities)
nil
No. and class of securities to
which interest relates
nil
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002